FGF23 and left ventricular hypertrophy: The proposed mechanism is that elevated serum levels of FGF23 lead to left ventricular hypertrophy and endothelial dysfunction, worsening arterial stiffness, and accelerated cardiovascular damage in patients with CKD24–29.